Gerson Pharma Solutions is devoted to helping pharmaceutical companies design and execute their preclinical drug development programs, interpreting the findings and most importantly putting the findings into perspective.  Extensive experience in toxicology; broad-based experience in Drug Metabolism, Pharmacokinetics and Pharmacology; Gerson Pharma Solutions can fulfill many of your company's preclinical drug development needs.

 

Dr. Ron Gerson

Dr. Ron Gerson

A board-certified Toxicologist with over 25 years of preclinical drug development experience, Dr. Gerson has written or directed the preparation of over twenty IND or "First in Man" packages for products from a broad variety of therapeutic areas and has progressed several drugs from discovery/early development through successful worldwide registration. He also has experience in the development of drug delivery devices, medical imaging agents and has lead many diligence teams evaluating potential in-licensing candidates and corporate acquisitions.